CORVUS PHARMACEUTICALS INC. - COMMON STOCK

Corvus Pharmaceuticals to Present Updated Mupadolimab (Anti-CD73) Data at 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

02 11 2021 15:05:01 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results

01 11 2021 15:05:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China

27 10 2021 15:05:01 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Updates on Mupadolimab (Anti-CD73) Programs in Oncology and Infectious Disease

22 9 2021 05:00:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences

07 9 2021 15:05:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China

16 8 2021 16:00:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results

02 8 2021 15:05:01 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-19 Due to Vaccine Effectiveness in Reducing Hospitalizations

15 7 2021 15:05:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

25 5 2021 15:05:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program

05 5 2021 08:00:01 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results

29 4 2021 15:05:01 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

25 3 2021 07:30:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences

05 3 2021 07:30:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock

17 2 2021 15:10:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

12 2 2021 08:00:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock

11 2 2021 15:01:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19

04 2 2021 06:30:00 提供 Nasdaq GlobeNewswire